Free public seminar: Malaria elimination - 'Shifting Priorities in Malaria Drug Discovery Research’ by Associate Professor Kathy Andrews
The World Health Organisation estimates there were ~214 million new cases and 438,000 deaths due to malaria in 2015.
While this represents a significant decline in morbidity and mortality over the past decade, there is no broadly effective licensed malaria vaccine available and all currently used antimalarial drugs are now under threat due to parasite drug resistance.
With ~3.2 billion people at risk of malaria and a global agenda focused on eradication, there is an urgent need to develop new drugs with novel modes of action for both the prevention and treatment of malaria.
In this presentation, the changing priorities in malaria drug discovery will be discussed in the context of the global agenda of malaria eradication and data presented on the development of new drug leads for malaria prevention.
Associate Professor Kathy Andrews (pictured above) obtained her PhD in Microbiology in 1998 from Griffith University. After carrying out postdoctoral research on a malaria vaccine project at the QIMR Berghofer Medical Research Institute, she was awarded a prestigious Alexander von Humboldt Fellowship to work on pregnancy malaria at Heidelberg University in Germany. She returned to the QIMR Berghofer in 2003 where she developed a research program focused on malaria drug discovery. In 2008 she won the Queensland Premiers Award for Medical Research for her “piggyback” approach to malaria drug discovery, and in 2009 she was recruited to the Griffith University Eskitis Institute for Drug Discovery and awarded an ARC Future Fellowship to work on epigenetic inhibitors for malaria. A/Professor Andrews is a former national Director of the Australian Society for Medical Research (ASMR), Executive Council member and Treasurer of the Australian Society for Parasitology, and national Committee member of the Australian Association of von Humboldt Fellows. She has published 78 papers, graduated seven PhD students and consistently attracted competitive grants to fund her research, including leading two recently funded NHMRC Project grants and an NHMRC European Union grant. A/Professor Andrews heads the Tropical Parasitology Laboratory at Griffith University with a focus on the identification and development of novel drug leads for malaria prevention and treatment.
Wednesday 15 June 2016
Cairns Institute Lecture Theatre D3.054 & videolinked to Townsville Building 040 Room 103